Inotrem
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model Inflammatory Bowel Diseases | — | 2023-01-31 |
| Completed | Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support COVID19 | Phase 2 | 2020-09-23 |
| Active Not Recruiting | Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock Shock, Septic | Phase 2 | 2019-11-13 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients Wit Shock, Septic | Phase 2 | 2017-07-03 |
| Completed | Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects Healthy Subjects | Phase 1 | 2016-04-01 |